Orally bioavailable nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimetics. |
| |
| Authors: | R M Keenan W H Miller L S Barton W E Bondinell R D Cousins D F Eppley S M Hwang C Kwon M A Lago T T Nguyen B R Smith I N Uzinskas C C Yuan |
| |
| Affiliation: | Research & Development Division, SmithKline Beecham Pharmaceuticals, Collegeville, PA 19426-0989, USA. |
| |
| Abstract: | A peptide RGD analog containing a novel 2-aminopyridine arginine mimetic was discovered to have good affinity and selectivity for the vitronectin receptor. Incorporation of the 2-aminopyridine arginine mimetic into the 3-oxo-1,4-benzodiazepine-2-acetic acid integrin antagonist series led to novel and potent nonpeptide vitronectin receptor antagonists with promising levels of oral bioavailability. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
